trending Market Intelligence /marketintelligence/en/news-insights/trending/k7zfhaTbGCQx5PVmUsmdLg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Elanco receives 2nd information request from US FTC over $7.6B Bayer deal

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Elanco receives 2nd information request from US FTC over $7.6B Bayer deal

Elanco Animal Health Inc. received a second information request from the U.S. Federal Trade Commission regarding its $7.6 billion acquisition of Bayer AG's animal health business.

Greenfield, Ind.-based Elanco said the request was part of the standard regulatory review process under the Hart-Scott-Rodino Act. The request essentially extends the waiting period imposed under the antitrust act for 30 days after the companies involved have provided the information sought.

The transaction, which is subject to regulatory approval and closing conditions, is still expected to close in mid-2020, according to Elanco.

Elanco has previously said the deal will double its companion animal business, advance the company's intentional portfolio mix transformation and create a balance between its food animal and companion animal segments.